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Prognostic tumor growth modeling via volumetric medical
imaging observations can potentially lead to better outcomes of
tumor treatment management and surgical planning. Recent ad-
vances of convolutional networks (ConvNets) have demonstrated
higher accuracy than traditional mathematical models can be
achieved in predicting future tumor volumes. This indicates
that deep learning based data-driven techniques may have great
potentials on addressing such problem. However, current 2D
image patch based modeling approaches can not make full use of
the spatio-temporal imaging context of the tumor’s longitudinal
4D (3D + time) patient data. Moreover, they are incapable
to predict clinically-relevant tumor properties, other than the
tumor volumes. In this paper, we exploit to formulate the tumor
growth process through convolutional Long Short-Term Memory
(ConvLSTM) that extract tumor’s static imaging appearances
and simultaneously capture its temporal dynamic changes within
a single network. We extend ConvLSTM into the spatio-temporal
domain (ST-ConvLSTM) by jointly learning the inter-slice 3D
contexts and the longitudinal or temporal dynamics from mul-
tiple patient studies. Our approach can incorporate other non-
imaging patient information in an end-to-end trainable manner.
Experiments are conducted on the largest 4D longitudinal tumor
dataset of 33 patients to date. Results validate that the proposed
ST-ConvLSTM model produces a Dice score of 83.2%±5.1%
and a RVD of 11.2%±10.8%, both statistically significantly
outperforming (p <0.05) other compared methods of traditional
linear model, ConvLSTM, and generative adversarial network
(GAN) under the metric of predicting future tumor volumes.
Additionally, our new method enables the prediction of both cell
density and CT intensity numbers. Last, we demonstrate the
generalizability of ST-ConvLSTM by employing it in 4D medical
image segmentation task, which achieves an averaged Dice score
of 86.3%±1.2% for left-ventricle segmentation in 4D ultrasound
with 3 seconds per patient case.
Index Terms—Tumor growth prediction, Deep learning, Convo-
lutional LSTM, Spatio-temporal Longitudinal Study, 4D Medical
Imaging.
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I. INTRODUCTION
Tumor growth modeling using medical images of longitudi-
nal studies is a challenging yet important problem in precision
and predictive medicine, because it may potentially lead to
better tumor treatment management and surgical planning for
patients. For example, treatments of pancreatic neuroendocrine
tumor (PanNET or PNET) include active surveillance, surgical
intervention, and medical treatment. Active surveillance is
undertaken if a PanNET does not reach 3 cm in diameter or a
tumor-doubling time <500 days; otherwise the corresponding
PanNET should be resected due to the high risk of metastatic
disease [1]. Medical treatment (e.g., everolimus) is for the
intermediate-grade (PanNETs with radiologic documents of
progression within the previous 12 months), advanced or
metastatic disease [2]. Therefore the patient-specific predic-
tion of PanNET’s growth pattern at earlier stages is highly
desirable, since it will assist decision making on different
treatment strategies to better manage the undergoing treatment
or surgical planning.
Conventionally, this task has been well exploited through
complex and sophisticated mathematical modeling [3]–[9],
which accounts for both cell invasion and mass-effect us-
ing reaction-diffusion equations and bio-mechanical models.
From there the actual tumor growth can be predicted by
personalizing the established model based on clinical imaging
derived tumor physiological parameters, such as morphology,
metabolic rate, and cell density. While these methods yield
informative results, most of them have not been able to utilize
the underlying statistical distributions of tumor growth patterns
in the studied patient population. The number of mathematical
model parameters is often very limited (e.g., 5 in [8]), which
might not be sufficient to model the inherent complexities of
the growing tumors.
Furthermore, two alternative approaches have been pro-
posed to predict tumor growth. 1) Assuming that the future
tumor growth pattern follows its past trend, optical flow
computing can be used to estimate previous voxel-level tumor
motions, and subsequently, to predict the future deformation
field via an autoregressive model [10]. Therefore the entire
future brain MR scan can be generated but the resulting tumor
volume still needs to be measured manually. For slow- and
fast-growing brain tumors, the method achieves 13.7% and
34.2% volumetric estimation errors, respectively. However this
approach does not involve the tumor growth pattern in pop-
ulation trend, and may over-simplify the essential challenge
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2because it only infers the future tumor imaging under a linear
way. 2) To address this issue, machine learning principle is
a potential solution to incorporate the population trend into
tumor growth modeling. The pioneer study [11] attempts to
model the glioma growth patterns as a pixel classification
problem where traditional machine learning pipeline of hand-
crafted feature extraction and selection and classifier training
is applied. Although only moderate levels of accuracy (where
both precision and recall values are 59.8% [11]) has been
achieved, this data-driven statistical learning approach has
shown its potential to tackle the highly changeling task of
glioma (as a fast-growing tumor) growth prediction. Neverthe-
less the hand-crafted imaging features could be compromised
by the limited understanding of tumor growth process, and
may not generalize well for other tumors.
Recently, statistical and deep learning framework [12] and
two-stream convolutional neural networks (ConvNets) [13]
have shown more compelling and improved performance than
the mathematical modeling approach [8] using the same pan-
creatic tumor dataset. More importantly, the later study [13]
demonstrate the effectiveness of deep ConvNets in characteriz-
ing two fundamental processes of both cell invasion and mass-
effect of tumor growth.
From [12], image patch based ConvNets extract deep image
features that are late-fused with clinical factors, followed by
a support vector machine (SVM) classifier using all features.
Such a separated process may not fully exploit the inherent
correlations between the deep image features and clinical
factors. The two-stream ConvNet architecture [13] treats the
prediction as a local patch-based classification task, which
does not consider the global information of the tumor structure
and its surrounding spatio-temporal context. Both methods
make predictions based on 2D image slices whereas the
tumor growth modeling is in fact a 4D (3D+time) problem.
Additionally, [12], [13] cannot predict other clinically relevant
properties, such as tumor cell density and radiodensity in
Hounsfield units (HU). Last, due to the difficulties in collecting
the longitudinal tumor data and the complexities of data
preprocessing, both studies are only conducted and evaluated
using a relatively small dataset consisting of ten patients.
In this paper, we propose a novel deep learning approach
that incorporates both 3D spatial and temporal image prop-
erties and clinical information into one single deep neural
network. Our main contributions are summarized as follows.
(1) A novel spatio-temporal Convolutional Long Short-Term
Memory (ST-ConvLSTM) network is proposed to jointly learn
the intra-slice spatial structures, the inter-slice correlations in
3D contexts, and the temporal dynamics in time sequences. (2)
Compared to previous machine (deep) learning based methods
[11]–[13] that utilize 2D image patches and predict the future
tumor volume only, our new model is holistic image-based
and enables the predictions of future tumor imaging properties,
i.e., future cell density and CT intensity numbers for relevant
clinical diagnosis. (3) Other clinical information, such as time
intervals can be fully integrated into our end-to-end trainable
deep learning framework. (4) To the best of our knowledge, we
construct the largest longitudinal pancreatic neuroendocrine
tumor (which is a relatively slow-growing tumor) growth
TABLE I
DEEP LEARNING BASED FUTURE IMAGE FRAME PREDICTION METHODS
AND THEIR KEY TECHNIQUES. CONVLSTM: CONVOLUTIONAL LONG
SHORT-TERM MEMORY; GAN: GENERATIVE ADVERSARIAL NETWORK.
ConvLSTM GAN Encoder-Decoder Motion
LSTM [20] - - -
ConvLSTM [21]
√
- - -
BeyondMSE [22] -
√
- -
Autoencoder [23]
√
-
√ √
CDNA [24]
√
- -
√
MCNet [14]
√
-
√ √
PredNet [25]
√
- - -
STNet [15]
√ √ √ √
VPN [16]
√
-
√
-
Hierarchical [26] - -
√
-
S2S-GAN [27] -
√
- -
DVF [28] - -
√ √
DM-GAN [17]
√ √ √ √
PredRNN [18]
√
- - -
SNCCL [29] -
√
- -
Two-stream [30] - -
√ √
Spatial-motion [19]
√ √ √ √
database to date (33 patients with serial CT imaging added),
enriching our previous dataset by more than 3 times [12],
[13]. (5) We demonstrate the effectiveness and high efficiency
of employing 4D ST-ConvLSTM for a 3D+time left-ventricle
ultrasound image segmentation task. Only a small subset of
sparsely-annotated 3D ultrasound volumes per time sequence
are required by ST-ConvLSTM.
II. RELATED WORK
In recent computer vision developments, the task of future
image frame prediction (i.e., predicting a visual pattern of
RGB raw pixels given a short video sequence) has attracted
great research interests [14]–[19]. It is closely related to
unsupervised feature learning and can enable intelligent agents
to react to the environments. Table I briefly summarizes recent
representative deep learning based approaches to tackle this
problem. There are mainly four key technique components
being exploited: convolutional LSTMs (ConvLSTM), gener-
ative adversarial network (GAN), encoder-decoder network,
and motion (mostly optical flow) cues.
LSTM [31] is designed for the next time-step status predic-
tion in a temporal sequence, and can be naturally extended
to predict the consequent frames from previous ones in a
video [20]. Next, ConvLSTM [21] is proposed to preserve
the spatial structure in both the input-to-state and state-
to-state transitions. Subsequently, ConvLSTM becomes the
backbone model of several video prediction approaches [14]–
[19], [23]–[25], where each work is enhanced with additional
improvements. For example, 1) optical flow is introduced in
an encoder-ConvLSTM-decoder framework [23] to explicitly
model the temporal dynamics; 2) ConvLSTM is reformulated
to predict motions from the current pixels to the next pixels
[24] with the goal of alleviating the blurry prediction images;
3) ConvLSTM is integrated in encoder-decoder networks to
estimate the discrete joint distributions of the RGB pixels
which archived the highest accuracy on the moving digits
dataset [16]; 4) additionally, a new spatiotemporal LSTM
unit [18] is designed to memorize both temporal and spatial
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Fig. 1. Image processing pipeline of constructing the tumor dataset for one time point.
representations, thus obtaining better performances than the
conventional LSTM.
In addition to ConvLSTM, ConvNets integrated with GAN
[22], [27], [29] based image generators represent the other
thread of promising solutions, especially effective on sharpen-
ing blurry predictions. Encoder-decoder networks [14]–[17],
[23], [26], [28] commonly serve as backbone deep learning ar-
chitectures to achieve the image-to-image prediction that typ-
ically contain multiple convolutional layers for subsampling
and several deconvolutional layers for upsampling. Compre-
hensive discussions of the above techniques are given in [15],
[17], [19], where state-of-the-art quantitative performances are
presented using video, vehicle and pedestrian datasets.
ConvLSTM has also been employed for 3D medical image
segmentation, and is an effective way of treating the 3D
volume as a sequence of 2D consecutive slices [32]–[34].
Compared to the 2D ConvNets-based segmentation, ConvL-
STM tends to be more robust and consistent inter-slice wise
since 3D contextual information is memorized and propagated
in the z-direction.
Beyond the problems of 3D medical image segmentation
(directly on 3D volumetric data scans) and natural video
prediction (using 2D image+time sequences), tumor growth
prediction is processed on 4D longitudinal volumetric patient
imaging scans. Desirable prediction models should not only re-
call the temporal evolution trend, but also keep consistent with
the tumor’s 3D spatial contexts. Motivated by this assumption,
we propose a novel ST-ConvLSTM network to explicitly
capture their dependencies among 2D image slices, through
the recurrent analysis over spatial and temporal dimensions
concurrently. An alternative way of extending ConvLSTM to
4D image is based on 3D ConvLSTM model [35]. However,
given the computational complexity of both 3D convolution
and LSTM, such a model is hard to train and get converged.
Furthermore, due to the large GPU memory consumption, its
input size is limited which potentially affects its performance.
4D medical image segmentation, such as the segmentation
of 3D+time ultrasound volumes [36], is another application
scenario of our ST-ConvLSTM model. Currently, 2D or 3D
ConvNets are the main deep neural network models to solve
4D segmentation problem. Although well-designed 2D/3D
ConvNets could produce promising accuracy, the 4th temporal
dimension contains the time-consistency constraints and can
potentially improve the 4D segmentation accuracy. However
direct usage of 4D ConvNets for segmentation is extremely
slow and less practical, mainly because of the large com-
putational complexity and the lack of 4D labels (e.g., the
manual segmentation annotations for all 3D image volumes
per sequence).
III. METHODS
A. Construction of 4D Longitudinal Tumor Dataset
Our 4D longitudinal tumor imaging data set used in this
study consists of dual-phase contrast-enhanced CT volumes at
three time points for each patient. As shown in Fig. 1, for each
pair of pre- and post-contrast (arterial phase) 3D CT volumes
at the same time point, their organ (e.g., pancreas) regions are
first roughly cropped and registered to post-contrast CT using
the ITK1 implementation of mutual information based B-spline
registration [37]. The segmentation is performed manually by a
medical trainee using ITK-SNAP [38]2 on the post-contrast CT
(as those tumors can be better evaluated in the arterial phase),
under supervision of an experienced radiologist. Three image
feature channels are derived: 1) intracellular volume fraction
(ICVF) images representing the cell density that is normalized
between [0 100] (more details about ICVF calculation can
be referred to [7]); 2) post-contrast CT images in soft-tissue
window [-100, 200HU] and linearly transformed to [0 255];
3) binary tumor segmentation mask (0 or 255). A sequence
of image patches of 32×32 pixels3 centered on the 3D tumor
centroid is cropped to cover the entire tumor. The cropping is
repeated for the three ICVF-CT-Mask channels (right panel in
Fig. 1) and forms an RGB image as illustrated in Fig. 2. The
dataset is prepared for every tumor volume at each time point,
and imaging volumes at different times are aligned using the
segmented 3D tumor centroids, to build the spatio-temporal
1https://itk.org/
2http://www.itksnap.org/
3Most pancreatic tumors in our dataset are <3 cm (≈30 pixels) in diameter.
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Fig. 2. Left: The proposed Spatio-Temporal Convolutional LSTM (ST-ConvLSTM, or ST-CLSTM) network for learning of 4D medical imaging representations
to predict tumor growth or segment object. In this example, 2 time points (each with 4 spatially adjacent image slices and each slice is a 3-channel color
image) are shown. This network model can be either used to predict tumor growth in 4D longitudinal data (i.e., to generate a future slice Ys,t+1) given the
input Xs,t; or segment objects in 3D+time images (i.e., to compute the current segmentation mask frame Ys,t from an input ultrasound image Xs,t in Sec.
IV-E). Right: The ST-ConvLSTM unit. The encoder-decoder architecture is depicted in Fig. 3.
sequence data set for training and testing. We acknowledge
that there might be some bias of using simple tumor centroids
for the longitudinal alignment, but this is a relatively (more)
reliable approach compared to the image appearance based
registration methods, based on our preliminary experiment and
past studies (e.g., [8], [12], [13]).
B. Spatio-Temporal Convolutional LSTM
1) Convolutional LSTM
LSTM [20] operates on temporal sequences of 1D vectors,
and can reconstruct the input sequences or predict the future
sequences. A LSTM unit contains a memory cell Ct, an input
gate it, a forget gate ft, an output gate ot, and an output
state Ht. Compared with the conventional LSTM, ConvLSTM
is capable of modeling 2D spatio-temporal image sequences
by explicitly encoding their 2D spatial structures (replacing
LSTM’s fully connected transformations with spatial local
convolutions in ConvLSTM) into the temporal domain [21],
[33]. The main equations of ConvLSTM are as follows:
ft = σ(Wxf ∗Xt +Whf ∗Ht−1 + bf )
it = σ(Wxi ∗Xt +Whi ∗Ht−1 + bi)
C˜t = tanh(WxC˜ ∗Xt +WhC˜ ∗Ht−1 + bC˜)
ot = σ(Wxo ∗Xt +Who ∗Ht−1 + bo)
Ct = ft  Ct−1 + it  C˜t
Ht = ot  tanh(Ct)
(1)
where σ and tanh are the sigmoid and hyperbolic tangent
non-linearities, ∗ is the convolution operator, and  is the
Hadamard product. The input Xt, cell Ct, hidden states Ht,
forget gate ft, input gate it, input-modulation gate C˜t, and
output gate ot are all 3D tensors with the dimension of M ×
N × F (rows, columns, feature maps). The memory cell Ct
is the key module, which acts as an accumulator of the state
information controlled by the gates.
2) ST-ConvLSTM Network and Unit
Given the ICVF-CT-Mask three-channel input maps at
time 1 and time 2 (as Xt = {Xit , Xct , Xmt }, t ∈ {1, 2},
respectively), the aim is to predict the output ICVF-CT-Mask
maps at time 3 (as Yt = {Y it , Y ct , Y mt }, t = 3), shown in
Fig. 2. Directly using ConvLSTM over temporal domain could
discover the tumor 2D dynamics for its growth prediction.
Furthermore, the spatial consistency in the 3D volume data
and its form of sequential nature of 2D image slices make it
possible to extend ConvLSTM to the 3D spatial domain.
Instead of simply concatenating the 2D CT slices, in order
to learn simultaneously both the spatial consistency patterns
among successive image slices and the temporal dynam-
ics across different time points, we propose a new Spatio-
Temporal Convolutional LSTM (ST-ConvLSTM) network as
illustrated in Fig. 2 (left panel). In this network, each ST-
ConvLSTM unit takes input from one image slice at one
time point in the 4D space, and receives the hidden states
from both the horizontal (the same slice locations at previous
time) and vertical directions (previous adjacent slice at the
current time). For example, the unit (s, t) in Fig. 2 (left
panel) corresponds to the sth slice at time t, and receives
the hidden states Hs,t−1 from unit (s, t − 1) and Hs−1,t
from unit (s − 1, t). Along with the current input image
slice Xs,t= {Xis,t, Xcs,t, Xms,t}, the ST-CLSTM unit (s, t) can
predict the future slice Ys,t+1= {Y is,t+1, Y cs,t+1, Y ms,t+1}, and
generate its hidden state Hs,t. For the 4D ultrasound image
segmentation task, the goal is from any current input raw
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Fig. 3. The end-to-end network architecture of our proposed encoder-ST-ConvLSTM-decoder for tumor growth prediction. For 4D segmentation task, the
input is replaced with the raw (e.g., ultrasound) image, the output is its mask, no “factor” branch for other clinical properties, and network model channels
are set to 1-8-16-32-64-64-64-32-16-1.
image slice (e.g., Xs,t) to generate its output segmentation
mask Y ms,t. In each ST-CLSTM unit (right in Fig. 2), since
there are two different candidates generated from the spatial
and temporal domains, respectively, two forget gates fSs,t and
fTs,t are equipped for adding them to update the unit state. The
activations of a ST-ConvLSTM at (s, t) are as follows:
fSs,t = σ(WxfS ∗Xs,t +WhsfS ∗Hs−1,t +WhtfS ∗Hs,t−1 + bfS )
fTs,t = σ(WxfT ∗Xs,t +WhsfT ∗Hs−1,t +WhtfT ∗Hs,t−1 + bfT )
is,t = σ(Wxi ∗Xs,t +Whsi ∗Hs−1,t +Whti ∗Hs,t−1 + bi)
C˜s,t = tanh(WxC˜ ∗Xs,t +WhsC˜ ∗Hs−1,t +WhtC˜ ∗Hs,t−1 + bC˜)
os,t = σ(Wxo ∗Xs,t +Whso ∗Hs−1,t +Whto ∗Hs,t−1 + bo)
Cs,t = f
S
s,t  Cs−1,t + fTs,t  Cs,t−1 + is,t  C˜s,t
Hs,t = os,t  tanh(Cs,t)
(2)
where the input Xs,t, cell Cs,t, hidden states Hs−1,t and
Hs,t−1, and gates fSs,t, f
T
s,t, is,t, C˜s,t, os,t are all 3D tensors
with dimensions of M×N×F (rows, columns, feature maps).
More precisely, Xs,t in Eq. (1) and Eq. (2) represents the
feature maps (i.e., 8 × 8 × 8 bottleneck in Fig. 3) after the
convolutional encoder on the input image.
The unit of ST-ConvLSTM (1,1) does not have any pre-
ceding units in both the spatial and temporal directions, and
units at time 1 level do not have the preceding units in their
temporal direction. Zeros activations are fed into these units.
The output hidden state of the last unit at time 1 level carries
all the tumor information at time 1, thus bringing the global
contexts to time 2 through the link connecting itself and
the first unit at time 2. It is worth mentioning that the ST-
ConvLSTM network is flexible that it can be easily extended to
receive more numbers of input time points or to predict longer
future steps by recursively applying the model. Moreover,
for 3D+time segmentation task, only sparsely-labeled manual
segmentations are required, e.g., representative volumes or
even slices.
3) End-to-End Architecture
We embed the ST-ConvLSTM unit in the encoder-decoder
architecture [16], [24] to make the end-to-end predictions, as
shown in Fig. 3 to replace the ST-ConvLSTM unit in Fig. 2.
In other words, Fig. 3 happens in every ST-CLSTM unit in
Fig. 2. Specifically, each frame Xs,t in the 4D spatio-temporal
space is recurrently passed into the encoder which consists
of four convolutional layers to encode a feature map. Along
with the image features, clinical factors have non-neglectful
influences on predicting the future image as well. We integrate
the related factors into our model by spatially tiling the factors
(i.e., m-dim vector) as a feature map with m-channels (m=1
in this paper, where only the time interval is added), which
is then concatenated to the output of conv4 which possesses
the smallest number of channels. The concatenated feature
map is then fed into a standard ST-ConvLSTM unit (Fig. 2)
with a 3×3 kernel and 8 hidden states for the spatio-temporal
modeling. As such, the ST-ConvLSTM determines the future
state by jointly considering or integrating the compact spatial
information of the current slice, the states of slices from
previous times and adjacent locations, and clinically relevant
factor(s). After that, the decoder with four deconvolutional
layers generates the future frame Ys,t+1. Because having a
smaller transitional kernel helps ConvLSTM to capture smaller
motions [21], we use a 3×3 convolutional kernel by taking
into account the knowledge prior that the pancreatic tumor in
our dataset is slow-growing. For fast-growing tumors, such as
glioma, a larger convolutional kernel should be used.
4) Network Training and Testing
For the tumor growth prediction task, during training, tumor
image slices from time 1 and time 2 are fed as inputs into
our network according to their corresponding spatio-temporal
locations. Image slices from time 2 and time 3 are used
to compute training loss. The objective function of our ST-
ConvLSTM network is designed to minimize the `2 loss
between the predicted frames Y and the true future frames
X at time 2 and time 3 (other losses, such as `1 and GDL
[22] have been tried, but `2 produces empirically better results
in our preliminary experiment):
L(X,Y ) =
2∑
t=1
S∑
s=1
`2(Ys,t+1, Xs,t+1) (3)
where S is the spatial sub-sequence length (set to 5 in our
current method). Note that minimizing the `2 loss only at time
3 will have slightly lower performances, and more importantly,
cannot maintain a reasonable performance on predicting time
6TABLE II
STATISTICS OF TUMOR GROWTH AT THE 1ST, 2ND, AND 3RD TIME POINTS
OF 33 PATIENTS.
1st-2nd 2nd-3rd
Days Growth (%) Days Growth (%) Size (cm3, 3rd)
Average 379±68 24.0±23.1 416±105 8.8±19.7 2.2±2.2
[min,max] [168,553] [-10.5,95.6] [221,804] [-23.2,68.8] [0.1,9.0]
2 which is not desired.
In testing, each spatial sequence (at time 1 and time 2)
is divided to several sub-sequences, and fed into our model
to generate predictions for time 3. These sub-sequences can
be either overlapping or non-overlapping. In our preliminary
experiment, no significantly differences are ever observed, so
we use the non-overlapping sub-sequences for efficiency. In
addition, our model is flexible to be extended to make pre-
diction at an arbitrary later time point given the observational
data of two previous time points, e.g., predicting time 4 based
on time 1 and time 2, by directly setting the value of factor
(as depicted in Fig. 3) as the time interval between time 2
and time 4. For the problem of 4D ultrasound image sequence
segmentation, refer the network training and testing details to
Sec. IV-E.
IV. EXPERIMENTS
A. Data and Protocol
Thirty-three patients (thirteen males and twenty females)
each with a PanNET are collected from the von Hippel-Lindau
(VHL) clinical trial at the National Institutes of Health. Each
patient has at least three time points (eleven of these patients
have the 4th time points) of dual-phase contrast-enhanced CT
imaging, with the time interval of 398±90 days (average±std).
The CT voxel sizes range between 0.60 × 0.60 × 1 mm3 —
0.98 × 0.98 × 1 mm3, and are resampled to 1 × 1 × 1 mm3
by trilinear interpolation. We did not include the modality
of FDG-PET imaging as it only exists in a small portion of
patients or time points. We acknowledge that the prediction
performance may not be optimal without PET information.
Nevertheless a CT-only predictive model can have wider
application scenario (e.g., when more specific PET imaging
is not available). The average age of patients and average
volume of tumors at time 1 are 50±11 years and 1.7±1.7
cm3, respectively. Fig. 4 shows the trajectories of PanNET
growth rates for different patients. The average information
of all 33 patients is shown in Table II. These tumors keep
slowly growing in general, but the growth speed is lower in
the 2nd-3rd time period. From the 1st to 2nd time points, only
one tumor shrinks. Such a number changes to twelve from the
2nd to 3rd time points. Only 11 patients have real imaging
data and time interval information at time 4.
B. Experimental Design & Implementation Details
Training details: Four data augmentation schemes are
performed to enrich our dataset. Besides the original axial
Fig. 4. Longitudinal trajectories of PanNET tumor volumes over a population
of 33 patients, from time 1 to time 3.
image slice sequences, we 1) reformat/reslice original volumes
to obtain coronal and sagittal slices, 2) rotate (with 90 degree
interval), 3) translate/shift (randomly 2 pixels in xy plane) for
each 4D ICVF-CT-Mask volumetric sequence, and 4) reverse
the slice order in spatial direction. Then, S=5 sub-sequences
are cropped from the augmented sequences (the minimal-
sized tumor in our dataset has about 5 slices), resulting in
172,296 training sub-sequences in total. Such methods add
more variations into the generated or augmented dataset and
improve the generalization capability. Note that we ensure the
augmented sequences are still spatio-temporally aligned. We
train our ST-ConvLSTM models for 5 epochs with the batch
size of 16. Each data point has 5 slices at three time points. We
use the ADAM optimizer [39] for neural network optimization
with an initial learning rate of 10−3.
Testing details: In the testing scenario, given any testing
PanNET data including pre- and post-contrast CT scans from
time 1 and time2 (Xt = {Xit , Xct , Xmt }, t ∈ {1, 2}), the
preprocessing steps in Sec. III-A are applied to first obtain the
aligned spatio-temporal ICVF-CT-Mask sequence pair. Next
we divide the aligned data into several non-overlapping sub-
sequence pairs: each sub-sequence image pair containing 5
consecutive slices from time 1 and their corresponding 5 from
time 2. By feeding these sub-sequence pairs together with
the time interval features as (time1–time2) and (time2–time3)
into our model, the future (at time 3) consecutive data slices
(Yt = {Y it , Y ct , Y mt }, t = 3) can be predicted and produced.
A thresholding value of 128 is applied upon the predicted
probability map of mask channel to obtain a binary tumor
mask Y m.
Comparison: We implement the current clinical practice
of a default linear growth model, the conventional ConvLSTM
[21], and another major deep learning method for video predic-
tion, i.e., BeyondMSE (GAN) [22], for model comparison. The
linear growth model assumes that tumors would keep their past
growing trend in the future. As detailed in [13], the past radial
expansion/shrink distances on tumor boundaries are used to
7expand/shrink the current tumor boundary as future prediction.
The ConvLSTM uses the same architecture as in Fig. 3 (but it
only captures the temporal dependencies) and is trained with
the same network optimization setting as ST-ConvLSTM. In
the BeyondMSE framework, a multi-scale fully convolutional
ConvNet is used as the future image generator, and a multi-
scale ConvNet as the discriminator. The generator receives
two past images as input and outputs one future image,
while the discriminator receives all three images as input to
classify whether they are real or fake. Our implementation
uses the same network architecture and parameter setting as
in [22]. Both ConvLSTM and BeyondMSE are trained for 5
epochs on the same augmented dataset as ST-ConvLSTM. All
these aforementioned models are implemented in TensorFlow
[40] and perform experiments on a DELL TOWER 7910
workstation with 2.40 GHz Xeon E5-2620 v3 CPU, 32 GB
RAM, and a Nvidia TITAN X Pascal GPU of 12 GB of
memory. Note that compared to previous machine (deep)
learning based tumor growth model prediction methods [11]–
[13] that merely utilize 2D image patches and only predict
the future tumor volume, our new ST-ConvLSTM model is
holistically 4D (volumetric+time) image-based and enables the
predictions of future tumor imaging properties, such as future
cell density and CT intensity numbers to assist relevant clinical
diagnosis.
Predicting a later future: In this experiment, we evaluate
the problem of predicting a later time step 4 given only time 1
and time 2 available. For those 11 patients who have follow-up
studies at time 4, we directly set the time interval between time
2 and time 4 as the feature in the trained predictive model.
For the remaining 22 patients without the follow-up time step
4, we assume that their time 3 and time 4 have the equal time
interval as the interval between their time 2 and time 3, in
order to investigate the effectiveness of time interval feature
in our predictive model on a larger patient cohort (of all 33
patient data).
C. Evaluation Methods
We evaluate our model using three-fold cross-validation. In
each fold, 22 patients are used as training and the remaining 11
patients as testing data. The performance of tumor prediction
is evaluated at the 3rd time point by the metrics of Dice
coefficient and RVD (relative volume difference) [8], [12], [13]
for tumor volume, RMSE (root-mean-squared error) for ICVF
[8], and diff.HU (difference of average HU values) for CT
value.
Dice =
2× TPV
Vpred + Vgt
RVD =
|Vpred − Vgt|
Vgt
RMSE =
√∑
((icvfpred − icvfgt)/icvfgt)2
TPV
diff.HU =
|HUpred −HUgt|
HUgt
(4)
where TPV (true positive volume) is the overlapping volume
between the predicted tumor volume Vpred and the ground
truth tumor volume Vgt. icvf represents the ICVF value of
a pixel. HU represents the average Hounsfield units within
a volume. Both RMSE and diff.HU are evaluated within the
TPV following [8], in which RMSE of ICVF prediction is
assessed in the TPV. Paired t-tests are conducted to compare
our new model and other previous methods.
We calculate the scatter plots of the ST-ConvLSTM pre-
dicted tumor volumes and the respective growth rates (Fig.
6), in comparison with the ground truth. Based on the tumor
growth rate, we also assess the performance of our method
on another clinical relevant prediction task – prediction of
tumor progression vs. regression at time 3. Specifically, the
prediction results are divided in two groups comprising tumor
progression (positive growth rate) and tumor regression (neg-
ative growth rate), where sensitivity and specificity are used
as evaluation metrics. As an alternative solution, traditional
machine learning methods are applied on this task by training
binary classifiers and evaluating using the same three-fold
cross-validation. Specifically, age, gender and tumor volume
measures at time 1 and time 2, tumor volume changes between
time 1 and time 2, are extracted as features for classification.
Optimal feature combinations are experimented and assessed
by several common classifiers including logistical regression,
linear SVM, neural network (one hidden layer), and random
forest.
We examine the contribution of each input feature channel,
by training with only one and predicting the corresponding
future one: for example, from given previous CT scans to
predict a future CT image. Note that RMSE and diff.HU
reported here are also evaluated within the true positive
volume.
D. Quantitative Results
The visual example in Fig. 5 shows the prediction results of
future CT scan, tumor mask/volume, and ICVF obtained by
ST-ConvLSTM (with time interval feature) and ConvLSTM.
In this case, compared with the conventional ConvLSTM, our
ST-ConvLSTM generates more spatially consistent prediction
towards the actual tumor in terms of CT, mask and ICVF, and
consequently, achieves better accuracies under all quantitative
metrics (i.e., diff.HU, Dice, RVD and RMSE). Table III reports
the overall performance of our ST-ConvLSTM model (with
and without time interval feature) with that of ConvLSTM
and the linear model on 33 patients. For the volume prediction,
ST-ConvLSTM (w. time) produces a Dice score of 83.2% and
a RVD of 11.2%. Both are significantly better than ConvL-
STM (p <0.01 and p <0.05) and linear predictive model
(p <0.001 and p <0.01). Furthermore, our model generates
a RMSE of 14.0% for tumor cell density prediction, and a
diff.HU of 10.2% for radiodensity prediction (no statistical
significances are achieved on these two metrics in comparison
to ConvLSTM). There is no significant difference between ST-
ConvLSTM with and without time interval feature.
The ST-ConvLSTM predicted tumor volumes achieve high
correlations against the ground truth volumes (linear correla-
tion coefficient r=0.96, the left panel in Fig. 6). However,
the prediction of tumor growth rate is highly challenging
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Fig. 5. An illustrated example shows the prediction results of CT, mask/volume, and ICVF of a tumor by ST-ConvLSTM and ConvLSTM. Note that the
tumor contours are superimposed on the ground truth CT images at time 3. Red: ground truth boundaries; Green: predicted tumor boundaries. In this example,
consecutive image slices with the spatial interval of two slices are shown for better visualization of the spatial changes/differences.
TABLE III
OVERALL QUANTITATIVE PERFORMANCE ON 33 PATIENTS UNDER 3-FOLD CROSS-VALIDATION – BASELINE LINEAR PREDICTIVE MODEL, CONVLSTM
[21], AND OUR ST-CONVLSTM. RESULTS ARE REPORTED AS: MEAN ± STD [MIN, MAX]. * OR ** INDICATES A STATISTICALLY SIGNIFICANT
DIFFERENCE OF OUR METHOD COMPARED TO OTHER METHODS AND BEYONDMSE (GAN), RESPECTIVELY. THERE IS NO SIGNIFICANT DIFFERENCE
BETWEEN ST-CONVLSTM WITH AND WITHOUT TIME INTERVAL FEATURE.
Volume-Dice (%) Volume-RVD (%) ICVF-RMSE (%) CT-HUdiff. (%)
Linear 73.0±6.2 [60.2, 85.1] 22.8±18.3 [5.1, 75.2] - -
ConvLSTM [21] 82.1±5.8 [65.6, 90.4] 14.1±12.4 [1.2, 50.4] 13.7±8.4 [6.8, 42.4] 10.4±8.3 [0.6, 32.4]
BeyondMSE (GAN) [22] 79.3±5.7 [65.6, 90.4] 20.9±14.4 [1.2, 50.4] 19.7±12.0 [6.8, 42.4] 10.7±8.1 [0.6, 32.4]
ST-ConvLSTM w/o. time 83.1±4.9* [67.9, 91.1] 12.6±9.0* [0.3, 48.6] 13.9±7.9** [7.8, 43.5] 10.0±7.3 [0.2, 26.3]
ST-ConvLSTM w. time 83.2±5.1* [69.7, 91.1] 11.2±10.8* [0.3, 46.5] 14.0±8.5** [7.4, 41.4] 10.2±8.5 [0.0, 35.0]
(with r=0.04, the right panel in Fig. 6), especially for some
extreme cases such as tumor shrink and aggressive progression
(quadrants II and IV in the right panel in Fig. 6). Thus we
assess the performance of a relatively more convenient binary
prediction task: tumor progression (positive growth rate, 21
patients) versus regression (negative growth rate, 12 patients).
As shown in Table IV, our method has a sensitivity of 76.2%
and specificity of 50%, in compared to an optimized machine
learning approach on this dataset that achieves a sensitivity
of 61.9% and specificity of 50%. This result is obtained by
a random forest classifier using the tumor volume at time 1
as the only feature (other feature combinations and classifiers
are empirically worse than this performance). The overall
available features and patient numbers for our studied problem
are still limited.
Figure 7 compares the prediction results of our ST-
ConvLSTM with BeyondMSE (GAN) [22]. In this case,
BeyondMSE has reported noticeably worse performance in
TABLE IV
PERFORMANCE OF PREDICTING TUMOR PROGRESSION VERSUS
REGRESSION BY ST-CONVLSTM AND AN OPTIMIZED MACHINE
LEARNING APPROACH ON THIS DATASET.
Sensitivity (%) Specificity (%)
Time 1’s tumor volume + random forest 61.9 50.0
ST-ConvLSTM 76.2 50.0
predicting tumor volume, but generates less blurry CT and
ICVF images (through visually observation). Table III lists
the overall prediction performance of BeyondMSE, where the
proposed method significantly outperforms BeyondMSE in
terms of Dice, RVD, and ICVF-RMSE.
Fig. 8 shows the prediction results at an even later time step
using ST-ConvLSTM for all 33 patients. As a result, 78.8%
tumors are predicted to keep growing at later time points – the
predicted volume at time 4 is larger than time 3. For the 11
tumors which have ground truth measures of tumor volume
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Fig. 6. Scatter plots of ST-ConvLSTM predicted tumor volumes versus ground truth values (r is the linear correlation coefficient) (Left) and predicted tumor
growth rates versus true rates (Right).
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Fig. 7. An example of image slices shows the prediction results of CT, mask/volume, and ICVF of a tumor by ST-ConvLSTM and BeyondMSE (GAN).
Note that the tumor contours are superimposed on the ground truth CT images at time 3. Red: ground truth boundaries; Green: predicted tumor boundaries.
TABLE V
ABLATION STUDY SHOWING RESULTS FOR DIFFERENT INPUT FEATURE
CHANNELS. * INDICATES A STATISTICALLY SIGNIFICANT DIFFERENCE.
Input channel Dice (%) RVD (%) RMSE (%) HUdiff. (%)
ICVF - - 15.7±8.9 -
CT - - - 12.1±10.8
Mask 83.6±4.7 13.7±11.9 - -
ICVF+CT+Mask 83.1±4.9 12.6±9.0 13.9±7.9* 10.0±7.3*
at time 4, our prediction produces a RVD of 37.2%±42.5%.
Fig. 9 illustrates qualitative tumor visualization results upon
changing the time interval feature, to examine the model’s
predictions at future possible time steps. From Table V, when
using the tumor mask as the single input channel, it produces
statistically similar Dice and RVD measures as three input
channels are utilized. However the three-channel ICVF-CT-
Mask input configuration generates clearly better performance
on RMSE and HUdiff. predictions.
On average, our method takes ∼ 1.2 hrs for training and 0.2
second for prediction per tumor. This performance is faster
than the statistical and deep learning framework (∼ 3.5 hrs
training and 4.8 mins prediction [12]) in both training and
inference; while faster than the two-stream ConvNets [13] in
prediction but slower in training.
E. Segmentation in 3D+Time Ultrasound
To further demonstrate the feasibility of ST-ConvLSTM for
4D segmentation, the publicly available 3D+time ultrasound
dataset CETUS [36] is used. The dataset is acquired from 15
patients where each patient containing 13–46 3D volumetric
image sequences and each sequence with two volumes being
manually segmented at the end-diastole (ED) and endsystole
(ES) phases. We resample all 3D ultrasound scans to 1mm3
isotropic resolution. For facilitating ST-ConvLSTM training,
the 4th dimension is downsampled to a constant length (i.e., 6
time points in our work), with image annotation/segmentation
masks at the 1st and 6th time points. All image slices are
resized to 96×96 pixels and pixel intensities are normalized
to [0, 1].
2D ultrasound image slices are fed as inputs into the
network according to their corresponding spatio-temporal loca-
tions to generate the corresponding segmentation masks, via a
`2 training loss computing only at two volumes from two time
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Fig. 9. One tumor example using ST-ConvLSTM predictions from time 1
(Day 0) and time 2 (Day 553), and at different later time points (Day 830,
1106, 1383, 1659). Note that the predicted tumor becomes larger when time
interval grows.
points (ED and ES phases). We train our model for 30 epochs
with the batch size of 1. Each data instance has 10 image slices
at 6 time points. We use ADAM optimizer [39] for the network
optimization with an initial learning rate of 10−3. In testing,
each sequence is divided to several sub-sequences and fed into
our model to generate the segmentation mask at each time.
The segmentation masks are post-processed with the largest
connected-component selection. Five-fold cross-validation at
the patient-level splitting is conducted.
Our method achieves the segmentation performance of Dice
at 86.8%±2.1% and 85.9%±1.6% for ED and ES phase,
respectively. Compared to the CETUS 2014 challenge winner
(89.4%±4.1% and 85.6%±5.7%, using deformable model
approach) [36], our method performs better for ES but worse
for ED. Fig. 10 shows an example of our 4D segmentation
result from ED to ES. Our method is efficient by taking
∼ 6.5 hrs for training of 30 epochs and only 3 seconds for
segmentation in testing per 4D sequence (6 ultrasound volumes
in our setting).
F. Discussion
Deep learning based precision and predictive medicine is
a new emerging research area, and has been shown to be
capable of outperforming traditional mathematical modeling
based methods for tumor growth prediction. This may suggest
its great potential for solving this complicated but important
problem. Because of the tremendous difficulties of collecting
the longitudinal tumor data, most previous studies are evalu-
ated on a relatively small sized dataset (i.e., < 10 patients).
A statistically larger and more representative patient dataset
is desired to evaluate the prediction performance. Our novel
model, ST-ConvLSTM network, significantly differs from the
most recent statistical and deep learning [12] and two-stream
ConvNets [13] in several key aspects. Firstly, it uses a single
recurrent neural network to explicitly and jointly model the
temporal changes and spatial consistency (i.e., in 4D space),
rather than separate invasion and expansion networks to model
the temporal information only (i.e., 2D+time) [12], [13]. Sec-
ondly, it makes prediction at the holistic image-level instead of
local image patch-level, integrating the global spatial context
of tumor structure and meanwhile being more computationally
efficient. Thirdly, it enables the prediction of both future
images and the associated imaging properties, including CT
scan, tumor cell density and radiodensity, as demonstrated in
this paper. Fourthly, it uses an encoder-decoder deep neural
network architecture that incorporates imaging feature and
clinical factor (such as time interval) in an end-to-end learning
framework, rather than a late feature fusion stage. Fifthly, we
construct the largest longitudinal tumor dataset (33 patients)
to date to the best of our knowledge, and comprehensive
quantitative evaluation results against three other prediction
methods using ConvLSTM [21] and GAN [22]. Finally, we
extend our deep learning based method to make it capable of
predicting any time point in a later future (beyond time point
3).
One of our main contributions is the novelty of proposed
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Fig. 10. 4D segmentation results of left ventricle in 3D+time ultrasound by ST-ConvLSTM.
ST-ConvLSTM architecture. Compared to the previous state-
of-the-art ConvLSTM [21] model for temporal modeling of 2D
image sequences across different time points, we substantially
extend the ConvLSTM into the spatio-temporal 4-dimensional
space by jointly leaning both the temporal evolution of tumor
growth and the spatial information of 3D consistency. Particu-
larly, for the adjacent 2D CT slices, they are also modeled by
ConvLSTM (slice-by-slice) to ensure their spatial consistency.
In addition, the global contexts of previous time point are
fed to the current time point. Therefore, each ST-ConvLSTM
unit makes prediction not only based on its local spatial
and temporal neighbors, but also from the whole information
of past states. As a result, our ST-ConvLSTM is able to
generate a sequence of images with better 4D properties
than ConvLSTM, e.g., producing statistically higher accuracy
in volume prediction, as shown in Table III. An illustrative
example can be observed from Fig. 5. ST-ConvLSTM gen-
erates more consistent tumor morphology and structure for
CT, mask, and ICVF predictions than ConvLSTM results (of
irregular predictions for tumor morphology). An alternative
option of using ConvLSTM for the 4D prediction task can
simply stack 2D CT slices as different input channels and
modeling the temporal relation using LSTM. However such
a method cannot exploit either the inherent correlations of
inter-slice correlations in 3D contexts, or temporal dynam-
ics across time points. The simple linear predictive model
performs the worst among all compared methods. This is in
agreement with the fact that the pancreatic neuroendocrine
tumors demonstrate nonlinear growth patterns [1], [41]. The
ablation study shows that directly predicting the future tumor
mask based on previous masks may perform comparably with
the configuration of using all three information (ICVF, CT,
mask). This is in accordance with the finding of a computer
vision study [27] that segmentation-to-segmentation predic-
tion generates no worse result than RGB+segmentation-to-
segmentation prediction. Of course, the complete ICVF-CT-
mask configuration offers better performance on RMSE and
HUdiff. predictions, and more importantly, can compute the
future tumor CT images (Fig. 9).
Beyond the tumor prediction task, our proposed novel
ST-ConvLSTM architecture can be adapted conveniently for
learning 4D medical image representations. We demonstrate
its promising accuracy and high efficiency (e.g., 3 seconds to
process per 4D imaging sequence) in 4D ultrasound image
segmentation, while only requiring sparse image annotation
masks (e.g., 2 out of 6 volumes per 4D sequence in our
experiment) for training. Furthermore, it can also be applied
to 4D classification task by changing the network output.
Besides ConvLSTM, BeyondMSE (GAN) [22] is another
deep learning model for future frame prediction. Benefited
from the `1, image gradient based optimization and adver-
sarial losses, GAN could generate less blurry future image
predictions, as shown in Fig. 7. However GAN has much
lower quantitative prediction performance than our method.
One reason may be that GAN does not explicitly model
the temporal dynamics, while LSTM has inherent temporal
“memory” units though GAN-based tumor prediction can
somewhat capture the tumor growing trend. For example, in
Fig. 7, from time 1 to time 2, the tumor invasion happens
mostly in its lower part so that GAN predicts the tumor to
continue infiltrating to the below area at time 3. Nevertheless
the tumor actually slows down its growing speed at time 3 in
that direction. Our ST-ConvLSTM model learns the spatio-
temporal information jointly and can leverage the current
slice’s global and local neighbors’ information, which results
in more robust prediction. On the other hand, the GAN-based
method may have higher overfitting risk on our task. The
network architectures used in [22] can be over-complicated
for the relatively small-sized data studied in this work.
Using time-interval feature in the ST-ConvLSTM does not
improve the prediction accuracy compared to without using
such feature. This may be because for time 1-2 and time 2-3
in our data, 1) the time-intervals are similar (about 1 year) for
different patients, and 2) the PanNet is slow-growing and can
show different growing trend. Actually, recent studies show
that time feature can be either helpful [42] or not helpful [43]
in LSTM-based prediction on different medical data. More
investigation is needed in this direction. Nevertheless, the time-
interval feature is necessary for tumor growth prediction prob-
lem. For example, for the prospect of longer future prediction
of tumor growth, the time-interval feature is effective to control
our predictive model to generate sensible prediction results, as
shown by the illustrative example in Fig. 9. Furthermore, our
model predicts that 78.8% tumors keep growing at time 4. This
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is in accordance with the natural history of PanNET tumors,
around 20% decreasing over a median follow-up duration of 4
years [41]. However, considering the missing of ground truths
of 22 patients at time 4, the related results and discussions
should be treated with caution. For the 11 patients with ground
truths at time 4, the prediction accuracy at a longer future time
point (i.e., RVD=37.2% at time 4) is much lower than that
of the next predictable time step (i.e., RVD=15.7% at time
3). This is as expected since it is indeed harder to precisely
predict the tumor growth trends and patterns after a longer
period of time, for example, around two years later using our
data. As a reference, a recent mathematical modeling based
tumor growth prediction method [9] has the relative volume
errors of later time predictions, ranging from 45% to 123% for
breast carcinoma. Another solution for predicting further into
the future is to recursively apply the two-time-input model as
in [27], i.e., predicting the outcome of time 4 based on the
time 2 and the predicted time 3 results.
There are some future directions which may further im-
prove our method. First, the `2 loss function used in our
model is the major reason that causes blurry predictions.
Adversarial training [22] can increase the sharpness of the
predicted image and is straightforward to be incorporated into
our ST-ConvLSTM network, through using a discriminator
to determine whether the generated future image sequence
is real or fake during training. Second, alternative network
architectures, such as skip and residual connections [16],
[24] may complement our current encoder-decoder network
as the backbone. Third, testing time data augmentation may
further improve the prediction performance, e.g., averaging
prediction results along three reconstruction directions: axial,
coronal, and sagittal. Fourth, predicting the tumor growth rate
is challenge for the current model. This may be caused by the
limited training data in which most tumors are slow-growing
whereas our model is not trained to directly predict the tumor
growth rate. Our deep model can scale well and perform
better by incorporating more patient data when available in the
future. Another potential solution is explicitly personalizing
the predictive model as in our previous work [13]. Although
obtaining much better result in predicting aggressive progres-
sion, we find that it decreases the overall volume prediction
accuracy (increasing RVD difference from 11.2% to 13.1%) on
our dataset. Nevertheless, our model shows competitive results
on predicting tumor progression versus regression compared
to traditional machine learning approaches.
V. CONCLUSION
In this paper, we have employed and substantially extended
ConvLSTM [21] in the 4-dimensional spatio-temporal do-
main for the task of modeling 4D longitudinal tumor data.
The novel ST-ConvLSTM network jointly learns the intra-
slice structures, the inter-slice 3D contexts, and the temporal
dynamics. Quantitative results of notably higher accuracies
than the original ConvLSTM [21] are reported, using several
metrics on predicting the future tumor volumes. Compared to
the most recent 2D+time deep learning based tumor growth
prediction models [12], [13], our new approach directly works
on 4D imaging space and incorporates clinical factors in an
end-to-end trainable manner. This method can also predict
the tumor cell density and radiodensity. Our experiments are
conducted on the largest longitudinal pancreatic tumor dataset
(33 patients) to date and demonstrate the validity of our
proposed method. In addition, ST-ConvLSTM enables effi-
cient and effective 4D medical image segmentation with only
sparse manual image annotations required. The presented ST-
ConvLSTM model can potentially enable other applications of
4D medical imaging applications.
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